Treatment Adherence clinical trials at UC Irvine

2 in progress, 0 open to eligible people

Showing trials for

  • Mobile Health for Adherence in Breast Cancer Patients

    Sorry, not currently recruiting here

    This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.

    Orange 5379513, California 5332921 and other locations

  • Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy

    Sorry, not yet accepting patients

    New oral anticancer treatments have improved survival across cancer types but introduced challenges in medication adherence and symptom management. The SMART pilot trial will test a new mobile health intervention that facilitates remote adherence and symptom monitoring, patient-provider communication outside of clinic visits regarding the use of oral anticancer treatments, and support for financial and social needs, as well as health literacy support, for 30 English- and Spanish-speaking patients. This study will increase understanding of barriers and facilitators to the use of the proposed mHealth intervention.

    Newport Beach 5376890, California 5332921 and other locations

Our lead scientists for Treatment Adherence research studies include .

Last updated: